Loading...
Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date
Relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) is associated with a poor prognosis in both children and adults. Traditionally, there were limited options for salvage therapy, which consisted mostly of conventional chemotherapy. However, in the past 5 years, novel agents have changed ou...
Na minha lista:
| Udgivet i: | Patient Relat Outcome Meas |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6173178/ https://ncbi.nlm.nih.gov/pubmed/30323696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S149420 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|